October 29, 2010

SILVER SPRING , Md. (Oct. 29) The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

October 28, 2010

The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency...

September 15, 2010

Drug maker Forest Pharmaceuticals will pay more than $300 million to the federal government as...